DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria
Year: 2026
Type: article
Abstract: LpxH is a key enzyme in the lipid A biosynthesis pathway and a promising target for the development of new antibiotics against Gram-negative pathogens. We report the discovery and optimization of two structurally distinct LpxH inhibitor series discovered through DNA-encoded chemical library (DEL) screening. Our DEL affinity selections identified a known sulfonyl piperazine class (Series 1), and a novel biphenyl-pyrimidine scaffold (Series 2) that represented a new chemical starting point for LpxH inhibitor development. To overcome liabilities, like poor solubility and low potency, a structure-based drug design approach was used for downstream hit expansion. Optimization of Series 1 yielded compound 14, which achieved wild-type activity against E. coli. Optimization of Series 2 led to compounds 21 and 24, displaying a MIC of 16 μg/mL against efflux-defective and hyperpermeable E. coli and a MIC of 8 μg/mL against efflux-defective E. coli respectively. Target engagement was confirmed via bacterial genetic sensitization experiments, demonstrating a LpxH-mediated mechanism of action.
Source: ACS Infectious Diseases
Authors: Christodoulos Mitrogiannis, Johan Wannberg, Edouard Zamaratski, Douglas L. Huseby, Sha Cao, Otto Lindahl, Stefan Lindström, Eldar Abdurakhmanov, Melania Minoia, John M. Pruneau, Xia Tian, Corey Bienstock, Paolo A. Centrella, Richard J. Fair, Marie-Aude Guié, Christopher D. Hupp, Jennifer Le-Marshall, Ying Zhang, Annette K. Roos, Sanjeewani Sooriyaarachchi, Sherry Mowbray, Diarmaid Hughes, S. Pauliina Turunen, Anders Karlén, Oscar Verho
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7171683301
